超声造影与微血流成像同步显示技术诊断肝脏肿瘤的初步应用
该研究纳入82例患者共82个局灶性肝脏病变,采用Philips EPIQ7超声系统比较CDFI、MFI与CEUS-MFI检测瘤内血管的能力,并比较CEUS与CEUS-MFI诊断肝脏肿瘤的准确性与置信度。结果表明CEUS-MFI检测瘤内血管优于MFI和CDFI,且能提高诊断准确性及放射科医生的诊断置信度。
要点
- CEUS-MFI检测瘤内血管显著优于MFI和CDFI(P=.000)。
- CEUS-MFI较单纯CEUS提高肝脏病变诊断准确性(P=.009)。
- 正确诊断病例中高置信度诊断比例由88.4%升至92.4%(P=.041)。
核心结论
- CEUS-MFI对检测肝脏瘤内血管敏感,可提高放射科医生诊断肝脏病变的准确性和置信度。
研究设计与样本
- 单中心前瞻性研究,纳入82例患者共82个局灶性肝脏病变,均接受CDFI、MFI、CEUS及CEUS-MFI检查,使用Philips EPIQ7超声成像系统。
关键影像表现/征象
- CEUS-MFI检测到的瘤内血管数量多于MFI(P=.000)和CDFI(P=.000)。
诊断标准与关键数值
- CEUS-MFI较CEUS提高肝脏病变诊断准确性(P=.009)。
- 正确诊断的肝脏病变中,高置信度诊断比例由CEUS的88.4%(61/69)提高至CEUS-MFI的92.4%(73/79)(P=.041)。
临床应用与阅片要点
- 在肝脏肿瘤超声诊断中,可联合应用CEUS与MFI同步显示技术,以更敏感地显示瘤内血管并提升诊断信心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the value of simultaneous display of contrast-enhanced ultrasound and micro-flow imaging technology (CEUS-MFI) in intra-tumoral vessel detection and hepatic tumor diagnosis.
METHODS: A total of 82 patients with 82 focal liver lesions were enrolled in this study. Each patient received ultrasound exams including color Doppler flow imaging (CDFI), micro-flow imaging (MFI), contrast-enhanced ultrasound (CEUS), and CEUS-MFI with a Philips EPIQ7 ultrasound imaging system. The intra-tumoral vessels detected by CDFI, MFI, and CEUS-MFI were compared, respectively. The accuracy and confidence of using CEUS and CEUS-MFI in diagnosing hepatic tumors were also compared.
RESULTS: CEUS-MFI was capable of detecting more hepatic intra-tumoral vessels than MFI (P = .000) and CDFI (P = .000). Compared with CEUS, CEUS-MFI improved the diagnostic accuracy of hepatic lesions (P = .009). Particularly, among the correctly diagnosed hepatic lesions, the number of cases where radiologists diagnosed with great confidence was increased from 88.4% (61/69) with CEUS only to 92.4% (73/79) with CEUS-MFI (P = .041).
CONCLUSIONS: CEUS-MFI is sensitive in detecting hepatic intra-tumoral vessels and can improve the accuracy and confidence of radiologists in diagnosing hepatic lesions.
引用
- Han, Ji, Huang, et al. The Preliminary Application of Simultaneous Display of Contrast-Enhanced Ultrasound and Micro-Flow Imaging Technology in the Diagnosis of Hepatic Tumors. J Ultrasound Med. 2022. PMID: 36217761. doi:10.1002/jum.16111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。